PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91019F00131Repurposing of macrolide antibiotic — University of Texas M D Anderson Cancer Center

University of Texas M D Anderson Cancer Center holds $28.1M across 39 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 2 related awards under parent 75N91019D00021. Competition previously drew 2 offers. Recompete timing centers on the Apr 14, 2027 PoP end — agencies typically plan 12–18 months ahead.

Nih Nci

Awarding office

University of Texas M D Anderson Cancer Center

Recipient

Apr 14, 2027

PoP end

$-822,758.71

Obligated

$8.7M

Potential

541714

NAICS

AN12

PSC

2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs University of Texas M D Anderson Cancer Center — $90

Contract facts

Federal

Contract number75N91019F00131

Also listed as75N91019D00021-75N91019F00131

AgencyNih Nci

Awarding officeNih Nci

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentUniversity of Texas M D Anderson Cancer Center

CAGE0KD38

UEIS3GMKS8ELA16

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN12

Parent IDIQ / IDV75N91019D00021

Place of performanceHOUSTON TX

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

Related solicitationN01CN7701918

PoP startApr 15, 2019

PoP end (current)Apr 14, 2027

Obligated$-822,758.71

Current value$8.7M

Potential value$8.7M

REPURPOSING OF MACROLIDE ANTIBIOTIC CLARITHROMYCIN FOR THE PREVENTION OF LUNG AND BREAST CANCER is a federal award for Nih Nci held by University of Texas M D Anderson Cancer Center. Estimated value $8.7M ($-822,758.71 obligated). Current period of performance ends Apr 14, 2027. Last award drew 2 bidders. Place of performance: HOUSTON TX. Related solicitation N01CN7701918.

REPURPOSING OF MACROLIDE ANTIBIOTIC CLARITHROMYCIN FOR THE PREVENTION OF LUNG AND BREAST CANCER

Recompete timing

Public

● Expiring in 219 days

Current PoP ends Apr 14, 2027 (219 days remaining). Agencies typically plan 12–18 months ahead — at 7.2 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

University of Texas M D Anderson Cancer Center — $28.1M obligated across 39 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($28.1M) · all agencies

Department of Health and Human Services (HHS)$27.0M · 96%Department of Veterans Affairs (VA)$1.1M · 4%

Related awards

Same parent · incumbent

36C24524P0903

MED PHYSICS PEER REVIEW SERVICES

$1.1M

Sep 30, 2027

75N97021C00001

OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC)

$8.7M

Aug 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N91019F00131?

75N91019F00131 (Repurposing of macrolide antibiotic) is a Nih Nci award with a potential value of $8.7M, currently held by University of Texas M D Anderson Cancer Center. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91019F00131?

Nih Nci awarded 75N91019F00131 to University of Texas M D Anderson Cancer Center (potential $8.7M).

Who is the incumbent on 75N91019F00131?

University of Texas M D Anderson Cancer Center is the incumbent with $28.1M across 39 related awards in SCOUT’s public footprint. The current period of performance ends Apr 14, 2027.

When does University of Texas M D Anderson Cancer Center’s 75N91019F00131 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 14, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N91019F00131 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Jan 9, 2026